Confirms

Trump’s Legal Setback: Three-Judge Panel Confirms Jury Verdict in Landmark Case

by

A three-judge panel has affirmed a jury’s decision in a significant case involving former President Donald Trump, marking a notable development in ongoing legal proceedings. The ruling, which emerged from the appeals court in New York, consolidates the previous verdict against Trump, underscoring the complexities surrounding his legal battles. The case revolves around allegations that Trump committed fraud by inflating the value of assets in financial statements. The jury, after careful deliberation, concluded that Trump had indeed misrepresented the worth of certain properties and business ventures, leading to misleading valuations. In their decision, the appellate … Read more

Court Confirms Stunning $445 Million Verdict Against Micron in Patent Dispute with Netlist

by

Boise, Idaho — A federal appeals court has reaffirmed a substantial jury verdict of $445 million against Micron Technology in a case involving patent infringement linked to memory modules. The decision represents a significant legal setback for the semiconductor company. The case stems from claims made by Netlist, a tech firm specializing in memory solutions. They alleged that Micron illegally used proprietary technology in producing its high-performance memory products. A jury initially ruled in favor of Netlist in 2022, awarding the company the hefty sum after determining that Micron had indeed infringed on its patents. … Read more

US Court Confirms FDA’s Decision to Ban Compounded Versions of Ozempic and Wegovy

by

A federal judge in New York has supported a U.S. Food and Drug Administration decision that prohibits the compounding of alternatives to the diabetes medication Ozempic and its weight-loss counterpart, Wegovy. The ruling comes amid soaring demand for these drugs, which have gained popularity for their effectiveness in managing weight. The case arose when a group of pharmacies sought to produce compounded versions of these medications, which are manufactured by Novo Nordisk. These compounded alternatives would allow pharmacists to create custom formulations for patients, yet the FDA argued that such practices may pose risks of … Read more

Intel Scores Legal Victory: Jury Confirms Fortress Investment Group’s Control Over VLSI, Sparking Potential $3 Billion Patent Reimbursement

by

AUSTIN, Texas — Intel has persuaded a jury that Fortress Investment Group controls VLSI Technology, a ruling that could significantly impact Intel’s financial obligations linked to allegations of patent infringement by VLSI. This decision could potentially reverse Intel’s previous payments exceeding $3 billion to VLSI related to these patent disputes. The heart of the contention lies in a licensing agreement Intel established with Finjan in 2012, which Intel claims should also extend to VLSI due to Fortress’s control over both entities. Intel argues that the agreement, which covers patents held by Finjan and other associated … Read more